GlassScriptPhysician profile
Khaldoon Alaswad
NPI 1093762205
$276,179.56
in general payments reported to CMS, 2019-2025
33 companies · $11K in 2025
The $11K reported for 2025 was more than what 89% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $119K · 2020: $54K · 2021: $48K · 2022: $17K · 2023: $24K · 2024: $3,779 · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $20K · Consulting Fee: $7,175 · Food and Beverage: $4,716 · Travel and Lodging: $3,843 · Honoraria: $2,750.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $19,875.00 |
| Consulting Fee | $7,175.00 |
| Food and Beverage | $4,716.02 |
| Travel and Lodging | $3,842.66 |
| Honoraria | $2,750.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $159,371.50 | 2019-2025 | Vitalyst, General - Vascular Access, Avvigo Guidance System |
| Cardiovascular Systems INC. | $37,870.01 | 2019-2022 | |
| Abbott Laboratories | $25,142.60 | 2019-2025 | Optis, Diamondback Coronary, Ultreon |
| Teleflex LLC | $13,371.22 | 2019-2024 | Turnpike, Guideliner, Warrior |
| Asahi Intecc USA, INC. | $12,466.67 | 2021-2023 | Asahi Ptca Guide Wire |
| Abiomed | $7,880.15 | 2019-2024 | Impella |
| Livanova USA, INC. | $7,084.72 | 2019-2023 | Lifesparc |
| Arrow International, INC. | $6,235.39 | 2022-2024 | |
| Bard Peripheral Vascular, INC. | $2,377.95 | 2021-2025 | Lutonix Drug Coated Balloon |
| Shockwave Medical, INC | $1,081.66 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Inari Medical, INC. | $824.46 | 2022-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Vascular Solutions, INC. | $500.00 | 2019 | |
| Edwards Lifesciences Corporation | $341.74 | 2023-2025 | Sapien 3 Ultra Resilia |
| Penumbra, INC. | $300.34 | 2022-2024 | Indigo System |
| Philips North America LLC | $251.55 | 2019-2025 | Coronary Other |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Getinge USA Sales, LLC | $140.77 | 2019-2021 | |
| Stryker Corporation | $132.12 | 2025 | Flowtriever, Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Biotronik INC. | $118.13 | 2023 | |
| Cardiva Medical, INC. | $86.95 | 2022-2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Medtronic, INC. | $80.58 | 2022-2024 | Symplicity G3 |
| Reflow Medical INC | $73.37 | 2024 | |
| Amgen INC. | $72.12 | 2022-2024 | Repatha |
| Kestra Medical Technology Services, INC. | $54.25 | 2024 | Assure Wcd |
| Chiesi USA, INC. | $51.03 | 2024-2025 | Kengreal, Cleviprex |
| Cardinal Health 200 LLC | $50.33 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $41.00 | 2019-2020 | |
| Siemens Medical Solutions USA, INC. | $34.51 | 2019-2021 | |
| Recor Medical INC | $31.37 | 2025 | Paradise Ultrasound Renal Denervation System |
| Medtronic Vascular, INC. | $30.97 | 2019 | |
| Verge Medical, INC. | $30.59 | 2023 | |
| Cordis US Corp. | $29.86 | 2024 | Mynx Control |
| Lantheus Medical Imaging, INC. | $21.65 | 2025 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$50,000.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Khaldoon Alaswad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.